The Pulse
April 28, 2021

Share


Here's what you need to know about Edmonton today.

Essentials

  • 12°C: Mainly cloudy. 30% chance of showers late in the morning and early afternoon. Wind becoming northwest 20 km/h in the afternoon. High 12. Wind chill minus 8 in the morning. (forecast)
  • 7pm: The Oilers (28-16-2) will play the Jets (27-18-3). (details)

Leduc scraps photo radar city-wide

Leduc scraps photo radar city-wide


By
in the Regional Roundup

Leduc city council has voted to get rid of automated traffic enforcement, including speed cameras and red light cameras, in favour of manned traffic stops.

One reason cited for the decision is a staffing increase to the Municipal Traffic Unit (MTU). But councillors also said during deliberations that they had received negative feedback from residents.

"We've heard the voice of this community with respect to photo radar and we're adapting our safety efforts resulting in a greater presence of manned enforcement," Mayor Bob Young said in a news release.

Young added that "vulnerable areas" like school zones will get the same amount of enforcement, but through MTU personnel as opposed to cameras.

A report from Leduc's administration says the city will lose $201,480 in budgeted revenues from photo radar tickets in 2021.

The province has been going after automated enforcement programs since 2019, when it issued a new set of restrictions that prohibited municipalities from installing new equipment or adding new enforcement locations.

Continue reading Share

Headlines


By
Permalink Share
U of A neurologist awarded $2.85M to fund ALS research

U of A neurologist awarded $2.85M to fund ALS research


By
in the Health Innovation Roundup

University of Alberta neurologist Dr. Sanjay Kalra has received a $2.85-million funding boost to work towards improving treatment options for patients with amyotrophic lateral sclerosis (ALS) and to conduct research that will help scientists better understand the causes of the disease.

The funding is a collaborative effort between Brain Canada and ALS Canada, as well as two U.S.-based pharmaceutical companies ― Alnylam Pharmaceuticals and Regeneron.

The grant will support Dr. Kalra and his team who are working on the Comprehensive Analysis Platform To Understand, Remedy, and Eliminate ALS (CAPTURE ALS) to enhance collaboration between researchers and people living with the neurological disease.

Kalra said the funding "enables access to an abundance of information that will lead to improvements in ALS treatments on a global scale."

Continue reading Share

Share: